Cargando…
Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention/Vigilance and Social Cognition in Patients with Schizophrenia
OBJECTIVE: Preclinical studies have reported that abnormal kynurenic acid (KYNA) may play a role in cognitive deficits. Schizophrenia (SCZ) is characterized by a wide range of cognitive deficits that may evolve from abnormal KYNA. This study aimed to explore the relationship between KYNA and cogniti...
Autores principales: | Huang, Xingbing, Ding, Wenhua, Wu, Fengchun, Zhou, Sumiao, Deng, Shuhua, Ning, Yuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986175/ https://www.ncbi.nlm.nih.gov/pubmed/32158211 http://dx.doi.org/10.2147/NDT.S239763 |
Ejemplares similares
-
Association between plasma homocysteine levels and cognitive deficits in Han Chinese patients with schizophrenia across age groups
por: Zhou, Sumiao, et al.
Publicado: (2021) -
Kynurenine pathway metabolites are associated with gray matter volume in subjects with schizophrenia
por: Zhou, Sumiao, et al.
Publicado: (2022) -
Decreased plasma concentrations of kynurenine and kynurenic acid in schizophrenia patients
por: Markovic, M., et al.
Publicado: (2023) -
Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia
por: Huo, Lijuan, et al.
Publicado: (2021) -
Effects of Mindfulness-Based Cognitive Therapy on Stigma in Female Patients With Schizophrenia
por: Tang, Qiubi, et al.
Publicado: (2021)